FINANCIALS

AMLX Amylyx Pharmaceuticals Inc 1658551

Income Statement
Revenue	amlx-20240930	416,000
Net Income	amlx-20240930	-72,704,000
Profit Margin		-17476.92%

Balance Sheet
Current Assets	245,263,000
Assets	250,713,000
Current Liabilities	53,915,000
Liabilities	54,510,000
Equity	196,203,000

Cash Flow Statement
Operating Cash Flow	-108,639,000
Investing Cash Flow	10,674,000

Market Analysis
Market Cap	194,103,155
Price	3.60
BVPS	55.45
PB	0.06
PS	116.65
FCF	-97,965,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view AMLX documents filed with the SEC.

AMLX Filings Clear

View A List of Tickers